Clinical Trial: A Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Initial Efficacy of JS212 in Subjects With Advanced Malignant Solid Tumour

U.S., March 22 -- ClinicalTrials.gov registry received information related to the study (NCT06888830) titled 'A Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Initial Efficacy of JS212 in Subjects With Advanced Malignant Solid Tumour' on March 17.

Brief Summary: This study is a Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Initial Efficacy of JS212 in Subjects with Advanced Malignant Solid Tumour. Patients will be enrolled in two stages: a dose-escalation stage and a dose expansion stage.

Study Start Date: April 30

Study Type: INTERVENTIONAL

Condition: Advanced Malignant Solid Tumours

Intervention: DRUG: JS212 for Injection

JS212 for Injection is administer...